106621,1,Admission,O
106621,1,Date,O
106621,1,:,O
106621,1,[,O
106621,1,**2167-8-29**,O
106621,1,],O
106621,1,Discharge,O
106621,1,Date,O
106621,1,:,O
106621,1,[,O
106621,1,**2167-9-9**,O
106621,1,],O
106621,1,Date,O
106621,1,of,O
106621,1,Birth,O
106621,1,:,O
106621,1,[,O
106621,1,**2096-2-18**,O
106621,1,],O
106621,1,Sex,O
106621,1,:,O
106621,1,M,O
106621,1,Service,O
106621,1,:,O
106621,1,MEDICINE,O
106621,1,Allergies,O
106621,1,:,O
106621,1,Bactrim,B-Drug
106621,1,/,O
106621,1,Penicillins,B-Drug
106621,1,Attending,O
106621,1,:,O
106621,1,[,O
106621,1,**First,O
106621,1,Name3,O
106621,1,(,O
106621,1,LF,O
106621,1,),O
106621,1,6169**,O
106621,1,],O
106621,1,Chief,O
106621,1,Complaint,O
106621,1,:,O
106621,1,altered,O
106621,1,mental,O
106621,1,status,O
106621,1,;,O
106621,1,transfer,O
106621,1,from,O
106621,1,MICU,O
106621,1,Major,O
106621,1,Surgical,O
106621,1,or,O
106621,1,Invasive,O
106621,1,Procedure,O
106621,1,:,O
106621,1,intubation,O
106621,1,;,O
106621,1,now,O
106621,1,s/p,O
106621,1,extubation,O
106621,1,History,O
106621,1,of,O
106621,1,Present,O
106621,1,Illness,O
106621,1,:,O
106621,1,71M,O
106621,1,with,O
106621,1,multiple,B-Reason
106621,1,myeloma,I-Reason
106621,1,currently,O
106621,1,on,O
106621,1,Velcade,B-Drug
106621,1,",",O
106621,1,mixed,O
106621,1,obstructive-restrictive,O
106621,1,lung,O
106621,1,disease,O
106621,1,",",O
106621,1,PAF,O
106621,1,",",O
106621,1,presented,O
106621,1,to,O
106621,1,the,O
106621,1,ED,O
106621,1,on,O
106621,1,[,O
106621,1,**2167-8-29**,O
106621,1,],O
106621,1,complaining,O
106621,1,of,O
106621,1,polyuria,O
106621,1,.,O
106621,1,Per,O
106621,1,sister,O
106621,1,",",O
106621,1,patient,O
106621,1,has,O
106621,1,been,O
106621,1,fatigued,O
106621,1,with,O
106621,1,poor,O
106621,1,po,O
106621,1,intake,O
106621,1,for,O
106621,1,several,O
106621,1,weeks,O
106621,1,.,O
106621,1,She,O
106621,1,is,O
106621,1,not,O
106621,1,aware,O
106621,1,of,O
106621,1,any,O
106621,1,acute,O
106621,1,changes,O
106621,1,in,O
106621,1,his,O
106621,1,health,O
106621,1,.,O
106621,1,She,O
106621,1,took,O
106621,1,him,O
106621,1,to,O
106621,1,his,O
106621,1,Velcade,B-Drug
106621,1,appointment,O
106621,1,on,O
106621,1,Friday,O
106621,1,",",O
106621,1,where,O
106621,1,he,O
106621,1,felt,O
106621,1,fatigued,B-ADE
106621,1,but,O
106621,1,was,O
106621,1,of,O
106621,1,normal,O
106621,1,mood,O
106621,1,and,O
106621,1,behavior,O
106621,1,.,O
106621,1,He,O
106621,1,received,O
106621,1,day,O
106621,1,4,O
106621,1,of,O
106621,1,his,O
106621,1,Velcade,B-Drug
106621,1,at,O
106621,1,this,O
106621,1,time,O
106621,1,as,O
106621,1,well,O
106621,1,as,O
106621,1,1u,O
106621,1,PRBCs,B-Drug
106621,1,.,O
106621,1,.,O
106621,1,His,O
106621,1,VS,O
106621,1,on,O
106621,1,presentation,O
106621,1,to,O
106621,1,the,O
106621,1,ED,O
106621,1,were,O
106621,1,T,O
106621,1,99.6,O
106621,1,",",O
106621,1,HR,O
106621,1,68,O
106621,1,",",O
106621,1,BP,O
106621,1,106/56,O
106621,1,",",O
106621,1,RR,O
106621,1,25,O
106621,1,",",O
106621,1,O2sat,O
106621,1,97,O
106621,1,%,O
106621,1,RA,O
106621,1,.,O
106621,1,His,O
106621,1,K,B-Reason
106621,1,was,I-Reason
106621,1,6.0,I-Reason
106621,1,",",O
106621,1,so,O
106621,1,he,O
106621,1,was,O
106621,1,given,O
106621,1,Kayexalate,B-Drug
106621,1,30g,O
106621,1,.,O
106621,1,On,O
106621,1,exam,O
106621,1,",",O
106621,1,he,O
106621,1,had,O
106621,1,RUQ,O
106621,1,tenderness,O
106621,1,with,O
106621,1,a,O
106621,1,normal,O
106621,1,RUQ,O
106621,1,ultrasound,O
106621,1,.,O
106621,1,He,O
106621,1,was,O
106621,1,also,O
106621,1,noted,O
106621,1,to,O
106621,1,be,O
106621,1,somewhat,O
106621,1,dyspneic,O
106621,1,with,O
106621,1,an,O
106621,1,elevated,O
106621,1,D-dimer,O
106621,1,so,O
106621,1,he,O
106621,1,was,O
106621,1,sent,O
106621,1,for,O
106621,1,a,O
106621,1,V/Q,O
106621,1,scan,O
106621,1,to,O
106621,1,rule,O
106621,1,out,O
106621,1,a,O
106621,1,PE,O
106621,1,.,O
106621,1,.,O
106621,1,Halfway,O
106621,1,through,O
106621,1,the,O
106621,1,scan,O
106621,1,",",O
106621,1,he,O
106621,1,became,O
106621,1,agitated,O
106621,1,and,O
106621,1,combative,O
106621,1,and,O
106621,1,had,O
106621,1,stool,O
106621,1,incontinence,O
106621,1,.,O
106621,1,His,O
106621,1,VS,O
106621,1,upon,O
106621,1,return,O
106621,1,were,O
106621,1,HR,O
106621,1,110,O
106621,1,",",O
106621,1,BP,O
106621,1,144/65,O
106621,1,",",O
106621,1,O2sat,O
106621,1,89,O
106621,1,%,O
106621,1,NRB,O
106621,1,.,O
106621,1,He,O
106621,1,was,O
106621,1,dyspneic,O
106621,1,",",O
106621,1,diaphoretic,O
106621,1,",",O
106621,1,and,O
106621,1,nonverbal,O
106621,1,.,O
106621,1,He,O
106621,1,was,O
106621,1,given,O
106621,1,Ativan,B-Drug
106621,1,1mg,O
106621,1,IV,O
106621,1,for,O
106621,1,agitation,B-Reason
106621,1,.,O
106621,1,On,O
106621,1,lung,O
106621,1,exam,O
106621,1,",",O
106621,1,he,O
106621,1,had,O
106621,1,very,O
106621,1,poor,O
106621,1,air,O
106621,1,movement,O
106621,1,.,O
106621,1,He,O
106621,1,was,O
106621,1,intubated,O
106621,1,in,O
106621,2,the,O
106621,2,ED,O
106621,2,for,O
106621,2,airway,O
106621,2,protection,O
106621,2,with,O
106621,2,altered,O
106621,2,mental,O
106621,2,status,O
106621,2,and,O
106621,2,hypoxic,O
106621,2,respiratory,O
106621,2,failure,O
106621,2,.,O
106621,2,CXR,O
106621,2,showed,O
106621,2,clear,O
106621,2,lungs,O
106621,2,.,O
106621,2,He,O
106621,2,was,O
106621,2,given,O
106621,2,Solumedrol,B-Drug
106621,2,125mg,O
106621,2,IV,O
106621,2,",",O
106621,2,Benadryl,B-Drug
106621,2,50mg,O
106621,2,IV,O
106621,2,",",O
106621,2,and,O
106621,2,Pepcid,B-Drug
106621,2,20mg,O
106621,2,IV,O
106621,2,to,O
106621,2,treat,O
106621,2,possible,O
106621,2,allergic,B-Reason
106621,2,reaction,I-Reason
106621,2,to,O
106621,2,the,O
106621,2,radionuclide,B-Drug
106621,2,material,I-Drug
106621,2,.,O
106621,2,He,O
106621,2,was,O
106621,2,also,O
106621,2,started,O
106621,2,on,O
106621,2,a,O
106621,2,propofol,B-Drug
106621,2,gtt,O
106621,2,for,O
106621,2,sedation,B-Reason
106621,2,and,O
106621,2,2L,O
106621,2,NS,B-Drug
106621,2,.,O
106621,2,He,O
106621,2,was,O
106621,2,admitted,O
106621,2,to,O
106621,2,the,O
106621,2,MICU,O
106621,2,for,O
106621,2,further,O
106621,2,management,O
106621,2,.,O
106621,2,.,O
106621,2,In,O
106621,2,the,O
106621,2,MICU,O
106621,2,",",O
106621,2,he,O
106621,2,was,O
106621,2,quickly,O
106621,2,weaned,O
106621,2,off,O
106621,2,of,O
106621,2,the,O
106621,2,ventilator,O
106621,2,and,O
106621,2,on,O
106621,2,to,O
106621,2,a,O
106621,2,nasal,O
106621,2,cannula,O
106621,2,at,O
106621,2,2L/min,O
106621,2,on,O
106621,2,the,O
106621,2,morning,O
106621,2,of,O
106621,2,[,O
106621,2,**2167-8-31**,O
106621,2,],O
106621,2,.,O
106621,2,His,O
106621,2,mental,O
106621,2,status,O
106621,2,remained,O
106621,2,somewhat,O
106621,2,impaired,O
106621,2,in,O
106621,2,that,O
106621,2,he,O
106621,2,was,O
106621,2,never,O
106621,2,fully,O
106621,2,oriented,O
106621,2,to,O
106621,2,place,O
106621,2,.,O
106621,2,He,O
106621,2,had,O
106621,2,2,O
106621,2,sets,O
106621,2,of,O
106621,2,blood,O
106621,2,cultures,O
106621,2,sent,O
106621,2,(,O
106621,2,though,O
106621,2,it,O
106621,2,'s,O
106621,2,unclear,O
106621,2,if,O
106621,2,he,O
106621,2,was,O
106621,2,ever,O
106621,2,febrile,O
106621,2,),O
106621,2,and,O
106621,2,grew,B-Reason
106621,2,gram,I-Reason
106621,2,(,I-Reason
106621,2,+,I-Reason
106621,2,),I-Reason
106621,2,cocci,I-Reason
106621,2,in,I-Reason
106621,2,pairs/clusters,I-Reason
106621,2,from,O
106621,2,3/4,O
106621,2,bottles,O
106621,2,;,O
106621,2,he,O
106621,2,was,O
106621,2,started,O
106621,2,on,O
106621,2,vancomycin,B-Drug
106621,2,.,O
106621,2,His,O
106621,2,sputum,O
106621,2,culture,O
106621,2,also,O
106621,2,had,O
106621,2,4+,O
106621,2,gram,O
106621,2,(,O
106621,2,+,O
106621,2,),O
106621,2,cocci,O
106621,2,in,O
106621,2,pairs/chains,O
106621,2,.,O
106621,2,His,O
106621,2,warfarin,B-Drug
106621,2,was,O
106621,2,initially,O
106621,2,held,O
106621,2,due,O
106621,2,to,O
106621,2,the,O
106621,2,possibility,O
106621,2,of,O
106621,2,an,O
106621,2,LP,O
106621,2,but,O
106621,2,this,O
106621,2,was,O
106621,2,never,O
106621,2,done,O
106621,2,since,O
106621,2,his,O
106621,2,mental,O
106621,2,status,O
106621,2,seemed,O
106621,2,to,O
106621,2,be,O
106621,2,improving,O
106621,2,.,O
106621,2,Past,O
106621,2,Medical,O
106621,2,History,O
106621,2,:,O
106621,2,Oncologic,O
106621,2,History,O
106621,2,:,O
106621,2,Multiple,B-Reason
106621,2,myeloma,I-Reason
106621,2,diagnosed,O
106621,2,in,O
106621,2,[,O
106621,2,**12/2164**,O
106621,2,],O
106621,2,after,O
106621,2,presenting,O
106621,2,with,O
106621,2,several,O
106621,2,months,O
106621,2,of,O
106621,2,diffuse,O
106621,2,bony,O
106621,2,pain,O
106621,2,;,O
106621,2,found,O
106621,2,to,O
106621,2,have,O
106621,2,numerous,O
106621,2,lytic,O
106621,2,bony,O
106621,2,lesions,O
106621,2,and,O
106621,2,a,O
106621,2,monocloncal,O
106621,2,kappa,O
106621,2,protein,O
106621,2,in,O
106621,2,his,O
106621,2,UPEP,O
106621,2,(,O
106621,2,>,O
106621,2,8,O
106621,2,grams,O
106621,2,of,O
106621,2,kappa,O
106621,2,proteinuria,O
106621,2,),O
106621,2,;,O
106621,2,diagnosed,O
106621,2,with,O
106621,2,stage,O
106621,2,IIIB,O
106621,2,kappa,O
106621,2,light,O
106621,2,chain,O
106621,2,multiple,O
106621,2,myeloma,O
106621,2,.,O
106621,2,He,O
106621,2,initially,O
106621,2,responded,O
106621,2,well,O
106621,2,to,O
106621,2,Decadron,B-Drug
106621,2,and,O
106621,2,was,O
106621,2,then,O
106621,2,intolerant,O
106621,2,to,O
106621,2,thalidomide,B-Drug
106621,2,/,O
106621,2,Decadron,B-Drug
106621,2,;,O
106621,2,he,O
106621,2,subsequently,O
106621,2,responded,O
106621,2,well,O
106621,2,to,O
106621,2,Cytoxan,B-Drug
106621,2,/,O
106621,2,Decadron,B-Drug
106621,2,with,O
106621,2,a,O
106621,2,marked,O
106621,2,decrease,O
106621,2,in,O
106621,2,his,O
106621,2,kappa,O
106621,2,excretion,O
106621,2,and,O
106621,2,improvement,O
106621,2,inhis,O
106621,2,renal,O
106621,2,function,O
106621,2,.,O
106621,2,In,O
106621,2,[,O
106621,2,**7-/2165**,O
106621,2,],O
106621,2,",",O
106621,2,he,O
106621,2,underwent,O
106621,2,an,O
106621,2,autologous,O
106621,2,SCT,O
106621,2,after,O
106621,2,treatment,O
106621,2,with,O
106621,2,high-dose,O
106621,3,melphalan,B-Drug
106621,3,.,O
106621,3,He,O
106621,3,went,O
106621,3,into,O
106621,3,remission,O
106621,3,at,O
106621,3,this,O
106621,3,time,O
106621,3,which,O
106621,3,he,O
106621,3,maintained,O
106621,3,until,O
106621,3,[,O
106621,3,**7-/2167**,O
106621,3,],O
106621,3,when,O
106621,3,he,O
106621,3,presented,O
106621,3,to,O
106621,3,the,O
106621,3,ED,O
106621,3,with,O
106621,3,dyspnea,O
106621,3,on,O
106621,3,exertion,O
106621,3,;,O
106621,3,he,O
106621,3,was,O
106621,3,found,O
106621,3,to,O
106621,3,have,O
106621,3,20,O
106621,3,grams,O
106621,3,of,O
106621,3,Bence,O
106621,3,[,O
106621,3,**Doctor,O
106621,3,Last,O
106621,3,Name,O
106621,3,**,O
106621,3,],O
106621,3,proteinuria,O
106621,3,and,O
106621,3,new,O
106621,3,diabetes,O
106621,3,insipidus,O
106621,3,.,O
106621,3,A,O
106621,3,bone,O
106621,3,marrow,O
106621,3,biopsy,O
106621,3,showed,O
106621,3,>,O
106621,3,60,O
106621,3,%,O
106621,3,plasma,O
106621,3,cells,O
106621,3,.,O
106621,3,He,O
106621,3,was,O
106621,3,pulsed,O
106621,3,with,O
106621,3,Decadron,B-Drug
106621,3,and,O
106621,3,discharged,O
106621,3,on,O
106621,3,po,O
106621,3,Decadron,B-Drug
106621,3,for,O
106621,3,his,O
106621,3,MM,B-Reason
106621,3,and,O
106621,3,intranasal,O
106621,3,ddAVP,B-Drug
106621,3,for,O
106621,3,his,O
106621,3,DI,B-Reason
106621,3,.,O
106621,3,On,O
106621,3,[,O
106621,3,**2167-8-25**,O
106621,3,],O
106621,3,",",O
106621,3,he,O
106621,3,was,O
106621,3,started,O
106621,3,on,O
106621,3,Velcade,B-Drug
106621,3,(,O
106621,3,in,O
106621,3,addition,O
106621,3,to,O
106621,3,his,O
106621,3,[,O
106621,3,**Hospital1,O
106621,3,**,O
106621,3,],O
106621,3,Decadron,B-Drug
106621,3,),O
106621,3,.,O
106621,3,He,O
106621,3,received,O
106621,3,days,O
106621,3,1,O
106621,3,and,O
106621,3,4,O
106621,3,of,O
106621,3,Velcade,B-Drug
106621,3,prior,O
106621,3,to,O
106621,3,this,O
106621,3,presentation,O
106621,3,.,O
106621,3,.,O
106621,3,.,O
106621,3,PMH,O
106621,3,:,O
106621,3,1,O
106621,3,.,O
106621,3,Multiple,B-Reason
106621,3,myeloma,I-Reason
106621,3,?,O
106621,3,?,O
106621,3,?,O
106621,3,?,O
106621,3,?,O
106621,3,?,O
106621,3,Stage,O
106621,3,IIIA,O
106621,3,with,O
106621,3,kappa,O
106621,3,light,O
106621,3,chains,O
106621,3,",",O
106621,3,diagnosed,O
106621,3,in,O
106621,3,[,O
106621,3,**12-27**,O
106621,3,],O
106621,3,.,O
106621,3,Extensive,O
106621,3,lytic,O
106621,3,bone,O
106621,3,lesions,O
106621,3,(,O
106621,3,mostly,O
106621,3,in,O
106621,3,pelvis,O
106621,3,and,O
106621,3,legs,O
106621,3,),O
106621,3,without,O
106621,3,renal,O
106621,3,involvement,O
106621,3,.,O
106621,3,s/p,O
106621,3,autologous,O
106621,3,stem,O
106621,3,cell,O
106621,3,transplantation,O
106621,3,in,O
106621,3,[,O
106621,3,**7-27**,O
106621,3,],O
106621,3,.,O
106621,3,Was,O
106621,3,in,O
106621,3,remission,O
106621,3,with,O
106621,3,Zometa,B-Drug
106621,3,qo,O
106621,3,month,O
106621,3,until,O
106621,3,[,O
106621,3,**8-18**,O
106621,3,],O
106621,3,when,O
106621,3,he,O
106621,3,had,O
106621,3,a,O
106621,3,marrow,O
106621,3,biopsy,O
106621,3,showing,O
106621,3,relapse,O
106621,3,.,O
106621,3,Started,O
106621,3,on,O
106621,3,Velcade,B-Drug
106621,3,on,O
106621,3,[,O
106621,3,**8-25**,O
106621,3,],O
106621,3,(,O
106621,3,last,O
106621,3,dose,O
106621,3,10/6,O
106621,3,),O
106621,3,.,O
106621,3,Followed,O
106621,3,by,O
106621,3,Dr,O
106621,3,[,O
106621,3,**First,O
106621,3,Name,O
106621,3,(,O
106621,3,STitle,O
106621,3,),O
106621,3,1557**,O
106621,3,],O
106621,3,.,O
106621,3,Baseline,O
106621,3,creatinine,O
106621,3,1.9-2.0,O
106621,3,.,O
106621,3,2,O
106621,3,.,O
106621,3,Diabetes,B-Reason
106621,3,insipidus,I-Reason
106621,3,-,O
106621,3,dx,O
106621,3,during,O
106621,3,[,O
106621,3,**7-29**,O
106621,3,],O
106621,3,hosp.,O
106621,3,",",O
106621,3,+,O
106621,3,water,O
106621,3,deprivation,O
106621,3,test,O
106621,3,and,O
106621,3,response,O
106621,3,to,O
106621,3,ddAVP,B-Drug
106621,3,(,O
106621,3,thus,O
106621,3,",",O
106621,3,likely,O
106621,3,central,O
106621,3,),O
106621,3,3,O
106621,3,.,O
106621,3,Hypertension,O
106621,3,4,O
106621,3,.,O
106621,3,Restrictive/Obstructive,O
106621,3,lung,O
106621,3,disease,O
106621,3,:,O
106621,3,Followed,O
106621,3,by,O
106621,3,Dr.,O
106621,3,[,O
106621,3,**Last,O
106621,3,Name,O
106621,3,(,O
106621,3,STitle,O
106621,3,),O
106621,3,**,O
106621,3,],O
106621,3,.,O
106621,3,5,O
106621,3,.,O
106621,3,Paroxysmal,B-Reason
106621,3,AFib,I-Reason
106621,3,-,O
106621,3,on,O
106621,3,Coumadin,B-Drug
106621,3,and,O
106621,3,rate-controlled,O
106621,3,6,O
106621,3,.,O
106621,3,Hypercholesterolemia,O
106621,3,7,O
106621,3,.,O
106621,3,Osteoarthritis,O
106621,3,s/p,O
106621,3,bilateral,O
106621,3,knee,O
106621,3,replacements,O
106621,3,in,O
106621,3,[,O
106621,3,**2160**,O
106621,3,],O
106621,3,",",O
106621,3,[,O
106621,3,**2161**,O
106621,3,],O
106621,3,8,O
106621,3,.,O
106621,3,MVA,O
106621,3,[,O
106621,3,**2147**,O
106621,3,],O
106621,3,--,O
106621,3,>,O
106621,3,Multiple,O
106621,3,bilateral,O
106621,3,fractured,O
106621,4,ribs,O
106621,4,",",O
106621,4,lumbar,O
106621,4,diskectomy,O
106621,4,.,O
106621,4,Social,O
106621,4,History,O
106621,4,:,O
106621,4,The,O
106621,4,patient,O
106621,4,is,O
106621,4,divorced,O
106621,4,.,O
106621,4,He,O
106621,4,currently,O
106621,4,lives,O
106621,4,alone,O
106621,4,.,O
106621,4,He,O
106621,4,has,O
106621,4,no,O
106621,4,children,O
106621,4,.,O
106621,4,He,O
106621,4,has,O
106621,4,a,O
106621,4,sister,O
106621,4,who,O
106621,4,lives,O
106621,4,nearby,O
106621,4,.,O
106621,4,Both,O
106621,4,he,O
106621,4,and,O
106621,4,his,O
106621,4,sister,O
106621,4,live,O
106621,4,in,O
106621,4,Mission,O
106621,4,[,O
106621,4,**Doctor,O
106621,4,Last,O
106621,4,Name,O
106621,4,**,O
106621,4,],O
106621,4,.,O
106621,4,He,O
106621,4,has,O
106621,4,another,O
106621,4,sister,O
106621,4,who,O
106621,4,lives,O
106621,4,in,O
106621,4,[,O
106621,4,**Name,O
106621,4,(,O
106621,4,NI,O
106621,4,),O
106621,4,15076**,O
106621,4,],O
106621,4,",",O
106621,4,who,O
106621,4,will,O
106621,4,be,O
106621,4,staying,O
106621,4,with,O
106621,4,him,O
106621,4,during,O
106621,4,his,O
106621,4,transplant,O
106621,4,recovery,O
106621,4,to,O
106621,4,help,O
106621,4,assist,O
106621,4,with,O
106621,4,meals,O
106621,4,and,O
106621,4,housekeeping,O
106621,4,.,O
106621,4,Retired,O
106621,4,meatworker,O
106621,4,originally,O
106621,4,from,O
106621,4,[,O
106621,4,**Doctor,O
106621,4,Last,O
106621,4,Name,O
106621,4,15076**,O
106621,4,],O
106621,4,with,O
106621,4,extensive,O
106621,4,travel,O
106621,4,history,O
106621,4,.,O
106621,4,Occ,O
106621,4,EtOH,O
106621,4,.,O
106621,4,No,O
106621,4,tobacco,O
106621,4,Family,O
106621,4,History,O
106621,4,:,O
106621,4,No,O
106621,4,known,O
106621,4,family,O
106621,4,history,O
106621,4,of,O
106621,4,cancer,O
106621,4,",",O
106621,4,hypertension,O
106621,4,",",O
106621,4,or,O
106621,4,DM,O
106621,4,.,O
106621,4,Mother,O
106621,4,died,O
106621,4,at,O
106621,4,36,O
106621,4,and,O
106621,4,father,O
106621,4,at,O
106621,4,65,O
106621,4,of,O
106621,4,unknown,O
106621,4,causes,O
106621,4,.,O
106621,4,Brother,O
106621,4,and,O
106621,4,sisters,O
106621,4,have,O
106621,4,heart,O
106621,4,disease,O
106621,4,.,O
106621,4,Physical,O
106621,4,Exam,O
106621,4,:,O
106621,4,PHYSICAL,O
106621,4,EXAM,O
106621,4,(,O
106621,4,upon,O
106621,4,transfer,O
106621,4,out,O
106621,4,of,O
106621,4,MICU,O
106621,4,),O
106621,4,:,O
106621,4,T,O
106621,4,97.7,O
106621,4,HR,O
106621,4,62,O
106621,4,BP,O
106621,4,137/76,O
106621,4,Sat,O
106621,4,96,O
106621,4,%,O
106621,4,2L,O
106621,4,Weight,O
106621,4,156.2,O
106621,4,lbs,O
106621,4,Gen,O
106621,4,:,O
106621,4,elderly,O
106621,4,man,O
106621,4,in,O
106621,4,NAD,O
106621,4,",",O
106621,4,intermittently,O
106621,4,somnolent,O
106621,4,HEENT,O
106621,4,:,O
106621,4,no,O
106621,4,obvious,O
106621,4,trauma,O
106621,4,",",O
106621,4,OP,O
106621,4,dry,O
106621,4,with,O
106621,4,no,O
106621,4,lesions,O
106621,4,Neck,O
106621,4,:,O
106621,4,JVP,O
106621,4,flat,O
106621,4,with,O
106621,4,no,O
106621,4,carotid,O
106621,4,bruits,O
106621,4,Pulm,O
106621,4,:,O
106621,4,poor,O
106621,4,inspiratory,O
106621,4,effort,O
106621,4,",",O
106621,4,no,O
106621,4,wheezes/rales/ronchi,O
106621,4,heard,O
106621,4,CV,O
106621,4,:,O
106621,4,regularly,O
106621,4,irregular,O
106621,4,",",O
106621,4,nl,O
106621,4,s1s2,O
106621,4,",",O
106621,4,no,O
106621,4,m/r/g,O
106621,4,Abd,O
106621,4,:,O
106621,4,soft,O
106621,4,",",O
106621,4,nondistended,O
106621,4,",",O
106621,4,moderate,O
106621,4,tenderness,O
106621,4,to,O
106621,4,deep,O
106621,4,palpation,O
106621,4,in,O
106621,4,RUQ,O
106621,4,",",O
106621,4,no,O
106621,4,[,O
106621,4,**Doctor,O
106621,4,Last,O
106621,4,Name,O
106621,4,515**,O
106621,4,],O
106621,4,",",O
106621,4,nl,O
106621,4,BS,O
106621,4,",",O
106621,4,tympanitic,O
106621,4,",",O
106621,4,no,O
106621,4,hepatosplenomegaly/masses,O
106621,4,",",O
106621,4,no,O
106621,4,rebound/guarding,O
106621,4,Extr,O
106621,4,:,O
106621,4,no,O
106621,4,clubbing,O
106621,4,",",O
106621,4,cyanosis,O
106621,4,",",O
106621,4,or,O
106621,4,edema,O
106621,4,;,O
106621,4,cool,O
106621,4,feet,O
106621,4,Skin,O
106621,4,:,O
106621,4,dry,O
106621,4,",",O
106621,4,cool,O
106621,4,",",O
106621,4,scaling,O
106621,4,;,O
106621,4,no,O
106621,4,rashes/breakdown,O
106621,4,Neuro,O
106621,4,:,O
106621,4,alert,O
106621,4,but,O
106621,4,mildly,O
106621,4,somnolent,O
106621,4,;,O
106621,4,oriented,O
106621,4,to,O
106621,4,self,O
106621,4,",",O
106621,4,``,O
106621,4,[,O
106621,4,**Month,O
106621,4,(,O
106621,4,only,O
106621,4,),O
106621,4,**,O
106621,4,],O
106621,4,[,O
106621,4,**2166**,O
106621,4,],O
106621,4,'',O
106621,4,",",O
106621,4,and,O
106621,4,oriented,O
106621,4,to,O
106621,4,``,O
106621,4,hospital,O
106621,4,'',O
106621,4,only,O
106621,4,when,O
106621,4,given,O
106621,4,choices,O
106621,4,;,O
106621,4,CN,O
106621,4,[,O
106621,4,**1-4**,O
106621,4,],O
106621,4,intact,O
106621,5,;,O
106621,5,5/5,O
106621,5,strength,O
106621,5,in,O
106621,5,all,O
106621,5,extremities,O
106621,5,Pertinent,O
106621,5,Results,O
106621,5,:,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,NEUTS-84.7*,O
106621,5,BANDS-0,O
106621,5,LYMPHS-10.4*,O
106621,5,MONOS-3.8,O
106621,5,EOS-1.0,O
106621,5,BASOS-0.1,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,WBC-7.2,O
106621,5,RBC-2.91*,O
106621,5,HGB-9.0*,O
106621,5,HCT-27.5*,O
106621,5,MCV-95,O
106621,5,MCH-30.9,O
106621,5,MCHC-32.6,O
106621,5,RDW-18.6*,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,IgG-376*,O
106621,5,IgA-32*,O
106621,5,IgM-13*,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,ALBUMIN-3.8,O
106621,5,PHOSPHATE-3.3,O
106621,5,MAGNESIUM-2.4,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,ALT,O
106621,5,(,O
106621,5,SGPT,O
106621,5,),O
106621,5,-58*,O
106621,5,AST,O
106621,5,(,O
106621,5,SGOT,O
106621,5,),O
106621,5,-33,O
106621,5,LD,O
106621,5,(,O
106621,5,LDH,O
106621,5,),O
106621,5,-504*,O
106621,5,ALK,O
106621,5,PHOS-83,O
106621,5,TOT,O
106621,5,BILI-0.2,O
106621,5,DIR,O
106621,5,BILI-0.1,O
106621,5,INDIR,O
106621,5,BIL-0.1,O
106621,5,[,O
106621,5,**2167-8-28**,O
106621,5,],O
106621,5,01:10PM,O
106621,5,GLUCOSE-116*,O
106621,5,UREA,O
106621,5,N-44*,O
106621,5,CREAT-1.6*,O
106621,5,SODIUM-143,O
106621,5,POTASSIUM-5.5*,O
106621,5,CHLORIDE-105,O
106621,5,TOTAL,O
106621,5,CO2-31,O
106621,5,ANION,O
106621,5,GAP-13,O
106621,5,[,O
106621,5,**2167-8-29**,O
106621,5,],O
106621,5,02:55PM,O
106621,5,ALT,O
106621,5,(,O
106621,5,SGPT,O
106621,5,),O
106621,5,-67*,O
106621,5,AST,O
106621,5,(,O
106621,5,SGOT,O
106621,5,),O
106621,5,-212*,O
106621,5,ALK,O
106621,5,PHOS-79,O
106621,5,AMYLASE-46,O
106621,5,TOT,O
106621,5,BILI-0.2,O
106621,5,[,O
106621,5,**2167-8-29**,O
106621,5,],O
106621,5,02:55PM,O
106621,5,GLUCOSE-174*,O
106621,5,UREA,O
106621,5,N-50*,O
106621,5,CREAT-1.5*,O
106621,5,SODIUM-138,O
106621,5,POTASSIUM-6.0*,O
106621,5,CHLORIDE-103,O
106621,5,TOTAL,O
106621,5,CO2-28,O
106621,5,ANION,O
106621,5,GAP-13,O
106621,5,[,O
106621,5,**2167-8-29**,O
106621,5,],O
106621,5,10:45PM,O
106621,5,TYPE-ART,O
106621,5,TIDAL,O
106621,5,VOL-550,O
106621,5,PO2-461*,O
106621,5,PCO2-48*,O
106621,5,PH-7.32*,O
106621,5,TOTAL,O
106621,5,CO2-26,O
106621,5,BASE,O
106621,5,XS,O
106621,5,--,O
106621,5,1,O
106621,5,INTUBATED-INTUBATED,O
106621,5,VENT-CONTROLLED,O
106621,5,Brief,O
106621,5,Hospital,O
106621,5,Course,O
106621,5,:,O
106621,5,In,O
106621,5,the,O
106621,5,MICU,O
106621,5,",",O
106621,5,he,O
106621,5,was,O
106621,5,quickly,O
106621,5,weaned,O
106621,5,off,O
106621,5,of,O
106621,5,the,O
106621,5,ventilator,O
106621,5,and,O
106621,5,on,O
106621,5,to,O
106621,5,a,O
106621,5,nasal,O
106621,5,cannula,O
106621,5,at,O
106621,5,2L/min,O
106621,5,on,O
106621,5,the,O
106621,5,morning,O
106621,5,of,O
106621,5,[,O
106621,5,**2167-8-31**,O
106621,5,],O
106621,5,.,O
106621,5,His,O
106621,5,mental,O
106621,5,status,O
106621,5,remained,O
106621,5,somewhat,O
106621,5,impaired,O
106621,5,in,O
106621,5,that,O
106621,5,he,O
106621,5,was,O
106621,5,never,O
106621,5,fully,O
106621,5,oriented,O
106621,5,to,O
106621,5,place,O
106621,5,.,O
106621,5,He,O
106621,5,had,O
106621,5,2,O
106621,5,sets,O
106621,5,of,O
106621,5,blood,O
106621,5,cultures,O
106621,5,sent,O
106621,5,(,O
106621,5,though,O
106621,5,it,O
106621,5,'s,O
106621,5,unclear,O
106621,5,if,O
106621,5,he,O
106621,5,was,O
106621,5,ever,O
106621,5,febrile,O
106621,5,),O
106621,5,and,O
106621,5,grew,O
106621,5,gram,B-Reason
106621,5,(,I-Reason
106621,5,+,I-Reason
106621,5,),I-Reason
106621,5,cocci,I-Reason
106621,5,in,I-Reason
106621,5,pairs/clusters,I-Reason
106621,5,from,O
106621,5,3/4,O
106621,5,bottles,O
106621,5,;,O
106621,5,he,O
106621,5,was,O
106621,5,started,O
106621,5,on,O
106621,5,vancomycin,B-Drug
106621,5,.,O
106621,5,His,O
106621,5,sputum,O
106621,5,culture,O
106621,5,also,O
106621,5,had,O
106621,5,4+,O
106621,5,gram,O
106621,5,(,O
106621,5,+,O
106621,5,),O
106621,5,cocci,O
106621,5,in,O
106621,5,pairs/chains,O
106621,5,.,O
106621,5,His,O
106621,5,warfarin,B-Drug
106621,5,was,O
106621,5,initially,O
106621,5,held,O
106621,5,due,O
106621,5,to,O
106621,5,the,O
106621,5,possibility,O
106621,5,of,O
106621,5,an,O
106621,5,LP,O
106621,5,but,O
106621,5,this,O
106621,5,was,O
106621,5,never,O
106621,5,done,O
106621,5,since,O
106621,5,his,O
106621,5,mental,O
106621,5,status,O
106621,5,seemed,O
106621,5,to,O
106621,5,be,O
106621,5,improving,O
106621,5,.,O
106621,5,.,O
106621,5,Upon,O
106621,5,transfer,O
106621,5,to,O
106621,5,the,O
106621,5,floor,O
106621,5,:,O
106621,5,.,O
106621,5,A/P,O
106621,5,:,O
106621,5,71M,O
106621,5,with,O
106621,5,multiple,O
106621,5,myeloma,O
106621,5,",",O
106621,5,mixed,O
106621,5,obstructive-restrictive,O
106621,5,lung,O
106621,5,disease,O
106621,5,",",O
106621,5,?,O
106621,5,DI,O
106621,5,",",O
106621,5,and,O
106621,5,PAF,O
106621,5,",",O
106621,5,admitted,O
106621,5,after,O
106621,5,acute,O
106621,5,episode,O
106621,5,of,O
106621,5,altered,O
106621,5,mental,O
106621,5,status,O
106621,5,(,O
106621,6,of,O
106621,6,unclear,O
106621,6,etiology,O
106621,6,),O
106621,6,now,O
106621,6,extubated,O
106621,6,and,O
106621,6,transferred,O
106621,6,out,O
106621,6,of,O
106621,6,the,O
106621,6,MICU,O
106621,6,.,O
106621,6,Gram,O
106621,6,(,O
106621,6,+,O
106621,6,),O
106621,6,cocci,O
106621,6,growing,O
106621,6,from,O
106621,6,blood,O
106621,6,.,O
106621,6,.,O
106621,6,#,O
106621,6,#,O
106621,6,ID,O
106621,6,:,O
106621,6,-,O
106621,6,[,O
106621,6,**1-24**,O
106621,6,],O
106621,6,blood,O
106621,6,culture,O
106621,6,bottles,O
106621,6,from,O
106621,6,admission,O
106621,6,grew,B-Reason
106621,6,vanc-sensitive,I-Reason
106621,6,coag,I-Reason
106621,6,negative,I-Reason
106621,6,Staph,I-Reason
106621,6,;,O
106621,6,he,O
106621,6,completed,O
106621,6,a,O
106621,6,10-day,O
106621,6,course,O
106621,6,of,O
106621,6,IV,O
106621,6,vancomycin,B-Drug
106621,6,and,O
106621,6,remained,O
106621,6,afebrile,O
106621,6,-,O
106621,6,sputum,O
106621,6,culture,O
106621,6,grew,O
106621,6,non-Pseudomonas,B-Reason
106621,6,gram,I-Reason
106621,6,negative,I-Reason
106621,6,rods,I-Reason
106621,6,(,O
106621,6,CXR,O
106621,6,normal,O
106621,6,),O
106621,6,;,O
106621,6,completed,O
106621,6,course,O
106621,6,of,O
106621,6,levofloxacin,B-Drug
106621,6,-,O
106621,6,ceftriaxone,B-Drug
106621,6,was,O
106621,6,added,O
106621,6,for,O
106621,6,3,O
106621,6,days,O
106621,6,(,O
106621,6,[,O
106621,6,**Date,O
106621,6,range,O
106621,6,(,O
106621,6,1,O
106621,6,),O
106621,6,18881**,O
106621,6,],O
106621,6,),O
106621,6,due,O
106621,6,to,O
106621,6,concern,O
106621,6,for,O
106621,6,meningitis,B-Reason
106621,6,with,O
106621,6,his,O
106621,6,second,O
106621,6,change,O
106621,6,in,O
106621,6,mental,O
106621,6,status,O
106621,6,(,O
106621,6,see,O
106621,6,below,O
106621,6,),O
106621,6,and,O
106621,6,was,O
106621,6,stopped,O
106621,6,once,O
106621,6,mental,O
106621,6,status,O
106621,6,returned,O
106621,6,to,O
106621,6,baseline,O
106621,6,and,O
106621,6,it,O
106621,6,became,O
106621,6,clear,O
106621,6,there,O
106621,6,was,O
106621,6,no,O
106621,6,meningitis,O
106621,6,.,O
106621,6,#,O
106621,6,Mental,B-ADE
106621,6,status,I-ADE
106621,6,change,I-ADE
106621,6,:,O
106621,6,-On,O
106621,6,the,O
106621,6,night,O
106621,6,of,O
106621,6,[,O
106621,6,**9-3**,O
106621,6,],O
106621,6,",",O
106621,6,the,O
106621,6,patient,O
106621,6,became,O
106621,6,acutely,O
106621,6,psychotic,O
106621,6,and,O
106621,6,agitated,O
106621,6,.,O
106621,6,He,O
106621,6,was,O
106621,6,very,O
106621,6,worried,O
106621,6,that,O
106621,6,people,O
106621,6,were,O
106621,6,smoking,O
106621,6,crack,O
106621,6,in,O
106621,6,the,O
106621,6,halls,O
106621,6,and,O
106621,6,that,O
106621,6,there,O
106621,6,were,O
106621,6,people,O
106621,6,trying,O
106621,6,to,O
106621,6,hurt,O
106621,6,the,O
106621,6,nurses,O
106621,6,and,O
106621,6,sabotage,O
106621,6,Dr,O
106621,6,[,O
106621,6,**Name,O
106621,6,(,O
106621,6,NI,O
106621,6,),O
106621,6,6168**,O
106621,6,],O
106621,6,practice,O
106621,6,.,O
106621,6,His,O
106621,6,warfarin,B-Drug
106621,6,and,O
106621,6,steroids,B-Drug
106621,6,were,O
106621,6,stopped,O
106621,6,at,O
106621,6,this,O
106621,6,time,O
106621,6,.,O
106621,6,A,O
106621,6,psych,O
106621,6,consult,O
106621,6,was,O
106621,6,obtained,O
106621,6,the,O
106621,6,next,O
106621,6,morning,O
106621,6,who,O
106621,6,recommended,O
106621,6,Haldol,B-Drug
106621,6,/,O
106621,6,Cogentin,B-Drug
106621,6,.,O
106621,6,He,O
106621,6,required,O
106621,6,sedation,B-Reason
106621,6,with,O
106621,6,Haldol,B-Drug
106621,6,/,O
106621,6,Ativan,B-Drug
106621,6,/,O
106621,6,Dilaudid,B-Drug
106621,6,to,O
106621,6,get,O
106621,6,a,O
106621,6,head,O
106621,6,CT,O
106621,6,(,O
106621,6,which,O
106621,6,was,O
106621,6,negative,O
106621,6,for,O
106621,6,a,O
106621,6,bleed,O
106621,6,),O
106621,6,.,O
106621,6,Following,O
106621,6,sedation,O
106621,6,",",O
106621,6,the,O
106621,6,next,O
106621,6,evening,O
106621,6,",",O
106621,6,he,O
106621,6,was,O
106621,6,noted,O
106621,6,to,O
106621,6,be,O
106621,6,very,O
106621,6,rigid,B-Reason
106621,6,and,O
106621,6,received,O
106621,6,an,O
106621,6,additional,O
106621,6,dose,O
106621,6,of,O
106621,6,Cogentin,B-Drug
106621,6,.,O
106621,6,A,O
106621,6,neuro,O
106621,6,consult,O
106621,6,was,O
106621,6,obtained,O
106621,6,the,O
106621,6,next,O
106621,6,day,O
106621,6,who,O
106621,6,recommended,O
106621,6,stopping,O
106621,6,Haldol,B-Drug
106621,6,due,O
106621,6,to,O
106621,6,the,O
106621,6,rigidity,B-ADE
106621,6,.,O
106621,6,Per,O
106621,6,neuro,O
106621,6,consult,O
106621,6,",",O
106621,6,an,O
106621,6,LP,O
106621,6,was,O
106621,6,attempted,O
106621,6,twice,O
106621,6,to,O
106621,6,rule,O
106621,6,out,O
106621,6,CNS,O
106621,6,infection,O
106621,6,",",O
106621,6,but,O
106621,6,the,O
106621,6,patient,O
106621,6,was,O
106621,6,too,O
106621,6,agitated,O
106621,6,;,O
106621,6,he,O
106621,6,was,O
106621,6,treated,O
106621,6,empirically,O
106621,6,with,O
106621,6,vanco,B-Drug
106621,6,/,O
106621,6,ceftriaxone,B-Drug
106621,6,until,O
106621,6,it,O
106621,6,was,O
106621,6,clear,O
106621,6,that,O
106621,6,there,O
106621,6,was,O
106621,6,no,O
106621,7,meningitis,O
106621,7,;,O
106621,7,he,O
106621,7,had,O
106621,7,a,O
106621,7,persistently,O
106621,7,non-focal,O
106621,7,neuro,O
106621,7,exam,O
106621,7,with,O
106621,7,no,O
106621,7,menigeal,O
106621,7,signs,O
106621,7,.,O
106621,7,An,O
106621,7,EEG,O
106621,7,showed,O
106621,7,nonspecific,O
106621,7,slowing,O
106621,7,consistent,O
106621,7,with,O
106621,7,his,O
106621,7,sedation,O
106621,7,.,O
106621,7,Infectious,O
106621,7,workup,O
106621,7,(,O
106621,7,CXRs,O
106621,7,",",O
106621,7,cultures,O
106621,7,),O
106621,7,remained,O
106621,7,negative,O
106621,7,and,O
106621,7,he,O
106621,7,remained,O
106621,7,afebrile,O
106621,7,.,O
106621,7,His,O
106621,7,mental,O
106621,7,status,O
106621,7,slowly,O
106621,7,returned,O
106621,7,to,O
106621,7,baseline,O
106621,7,overnight,O
106621,7,on,O
106621,7,[,O
106621,7,**2171-9-6**,O
106621,7,],O
106621,7,",",O
106621,7,presumably,O
106621,7,as,O
106621,7,the,O
106621,7,effects,O
106621,7,of,O
106621,7,the,O
106621,7,steorids,B-Drug
106621,7,wore,O
106621,7,off,O
106621,7,.,O
106621,7,He,O
106621,7,was,O
106621,7,taken,O
106621,7,off,O
106621,7,of,O
106621,7,1:1,O
106621,7,observation,O
106621,7,and,O
106621,7,remained,O
106621,7,calm,O
106621,7,and,O
106621,7,cooperative,O
106621,7,.,O
106621,7,Further,O
106621,7,psychoactive,B-Drug
106621,7,meds,I-Drug
106621,7,(,O
106621,7,except,O
106621,7,for,O
106621,7,pain,B-Drug
106621,7,control,I-Drug
106621,7,meds,I-Drug
106621,7,),O
106621,7,were,O
106621,7,held,O
106621,7,.,O
106621,7,.,O
106621,7,#,O
106621,7,#,O
106621,7,Multiple,B-Reason
106621,7,myeloma,I-Reason
106621,7,:,O
106621,7,Currently,O
106621,7,on,O
106621,7,Velcade,B-Drug
106621,7,",",O
106621,7,last,O
106621,7,dose,O
106621,7,10/6,O
106621,7,",",O
106621,7,and,O
106621,7,dexamethasone,B-Drug
106621,7,.,O
106621,7,-,O
106621,7,he,O
106621,7,was,O
106621,7,continued,O
106621,7,on,O
106621,7,his,O
106621,7,outpatient,O
106621,7,dexamethasone,B-Drug
106621,7,regimen,O
106621,7,(,O
106621,7,8mg,O
106621,7,po,O
106621,7,bid,O
106621,7,),O
106621,7,but,O
106621,7,this,O
106621,7,was,O
106621,7,stopped,O
106621,7,on,O
106621,7,[,O
106621,7,**9-6**,O
106621,7,],O
106621,7,when,O
106621,7,he,O
106621,7,developed,O
106621,7,psychosis,B-ADE
106621,7,;,O
106621,7,there,O
106621,7,were,O
106621,7,some,O
106621,7,indications,O
106621,7,that,O
106621,7,he,O
106621,7,might,O
106621,7,not,O
106621,7,have,O
106621,7,been,O
106621,7,taking,O
106621,7,this,O
106621,7,at,O
106621,7,home,O
106621,7,",",O
106621,7,and,O
106621,7,his,O
106621,7,self-limited,B-ADE
106621,7,psychosis,I-ADE
106621,7,was,O
106621,7,thought,O
106621,7,to,O
106621,7,be,O
106621,7,secondary,O
106621,7,to,O
106621,7,the,O
106621,7,steroids,B-Drug
106621,7,.,O
106621,7,#,O
106621,7,#,O
106621,7,?,O
106621,7,DI/endocrine,B-Reason
106621,7,:,O
106621,7,-,O
106621,7,during,O
106621,7,previous,O
106621,7,admission,O
106621,7,there,O
106621,7,was,O
106621,7,a,O
106621,7,reported,O
106621,7,history,O
106621,7,of,O
106621,7,diabetes,O
106621,7,insipidus,O
106621,7,;,O
106621,7,a,O
106621,7,water,O
106621,7,deprivation,O
106621,7,test,O
106621,7,was,O
106621,7,done,O
106621,7,during,O
106621,7,that,O
106621,7,admission,O
106621,7,",",O
106621,7,though,O
106621,7,endocrine,O
106621,7,did,O
106621,7,not,O
106621,7,see,O
106621,7,the,O
106621,7,patient,O
106621,7,.,O
106621,7,Endocrine,O
106621,7,was,O
106621,7,consulted,O
106621,7,this,O
106621,7,time,O
106621,7,and,O
106621,7,recommended,O
106621,7,a,O
106621,7,pituitary,O
106621,7,MRI,O
106621,7,which,O
106621,7,showed,O
106621,7,a,O
106621,7,lack,O
106621,7,of,O
106621,7,expected,O
106621,7,hyperintensity,O
106621,7,in,O
106621,7,the,O
106621,7,neurohypophysis,O
106621,7,.,O
106621,7,No,O
106621,7,water,O
106621,7,deprivatino,O
106621,7,test,O
106621,7,was,O
106621,7,done,O
106621,7,",",O
106621,7,though,O
106621,7,his,O
106621,7,ddAVP,B-Drug
106621,7,was,O
106621,7,stopped,O
106621,7,when,O
106621,7,he,O
106621,7,became,O
106621,7,psychotic,B-ADE
106621,7,and,O
106621,7,his,O
106621,7,sodium,O
106621,7,remained,O
106621,7,normal,O
106621,7,with,O
106621,7,normal,O
106621,7,urine,O
106621,7,output,O
106621,7,.,O
106621,7,Per,O
106621,7,endo,O
106621,7,",",O
106621,7,he,O
106621,7,does,O
106621,7,not,O
106621,7,need,O
106621,7,to,O
106621,7,be,O
106621,7,on,O
106621,7,ddAVP,B-Drug
106621,7,.,O
106621,7,Also,O
106621,7,noted,O
106621,7,were,O
106621,7,low,O
106621,7,TSH,O
106621,7,",",O
106621,7,T4,O
106621,7,",",O
106621,7,T3,O
106621,7,",",O
106621,7,fT4,O
106621,7,levels,O
106621,7,.,O
106621,7,A,O
106621,7,rT3,O
106621,7,was,O
106621,7,slightly,O
106621,7,high,O
106621,7,and,O
106621,7,endocrine,O
106621,7,recommended,O
106621,7,repeat,O
106621,7,thyroid,O
106621,7,functino,O
106621,7,tests,O
106621,7,in,O
106621,7,[,O
106621,7,**12-26**,O
106621,7,],O
106621,7,weeks,O
106621,7,(,O
106621,7,suspect,O
106621,7,sick,O
106621,7,euthyroid,O
106621,7,),O
106621,7,for,O
106621,7,follow-up,O
106621,7,with,O
106621,7,no,O
106621,7,thyroid,O
106621,7,replacement,O
106621,7,at,O
106621,7,this,O
106621,7,time,O
106621,7,.,O
106621,7,.,O
106621,8,#,O
106621,8,#,O
106621,8,Obstructive/restrictive,B-Reason
106621,8,lung,I-Reason
106621,8,disease,I-Reason
106621,8,:,O
106621,8,Unclear,O
106621,8,etiology,O
106621,8,.,O
106621,8,MRI,O
106621,8,chest,O
106621,8,showed,O
106621,8,no,O
106621,8,PE,O
106621,8,and,O
106621,8,PA,O
106621,8,hypertension,O
106621,8,-,O
106621,8,continued,O
106621,8,Advair,B-Drug
106621,8,-,O
106621,8,weaned,O
106621,8,off,O
106621,8,of,O
106621,8,O2,O
106621,8,as,O
106621,8,tolerated,O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,PAF,B-Reason
106621,8,:,O
106621,8,Currently,O
106621,8,rate-controlled,O
106621,8,.,O
106621,8,-,O
106621,8,cont,O
106621,8,metoprolol,B-Drug
106621,8,and,O
106621,8,short-acting,O
106621,8,diltiazem,B-Drug
106621,8,for,O
106621,8,rate,B-Reason
106621,8,control,I-Reason
106621,8,-,O
106621,8,warfarin,B-Drug
106621,8,was,O
106621,8,stopped,O
106621,8,due,O
106621,8,to,O
106621,8,mental,O
106621,8,status,O
106621,8,changes,O
106621,8,;,O
106621,8,with,O
106621,8,his,O
106621,8,continued,O
106621,8,gait,O
106621,8,instability,O
106621,8,",",O
106621,8,it,O
106621,8,was,O
106621,8,deemed,O
106621,8,too,O
106621,8,unsafe,O
106621,8,for,O
106621,8,him,O
106621,8,to,O
106621,8,continue,O
106621,8,warfarin,B-Drug
106621,8,",",O
106621,8,especially,O
106621,8,since,O
106621,8,he,O
106621,8,was,O
106621,8,not,O
106621,8,in,O
106621,8,AFib,O
106621,8,at,O
106621,8,all,O
106621,8,during,O
106621,8,the,O
106621,8,admisison,O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,Endocrine,O
106621,8,-,O
106621,8,dexamethasone,B-Drug
106621,8,as,O
106621,8,above,O
106621,8,-,O
106621,8,TSH,O
106621,8,",",O
106621,8,T4,O
106621,8,",",O
106621,8,fT4,O
106621,8,all,O
106621,8,low,O
106621,8,;,O
106621,8,?,O
106621,8,sick,O
106621,8,euthyroid,O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,Hypertension,B-Reason
106621,8,:,O
106621,8,-,O
106621,8,continued,O
106621,8,on,O
106621,8,his,O
106621,8,metoprolol,B-Drug
106621,8,and,O
106621,8,diltiazem,B-Drug
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,FEN,B-Reason
106621,8,:,O
106621,8,Poor,O
106621,8,po,O
106621,8,intake,O
106621,8,x,O
106621,8,weeks,O
106621,8,per,O
106621,8,sister,O
106621,8,;,O
106621,8,NPO,O
106621,8,in,O
106621,8,MICU,O
106621,8,-,O
106621,8,500cc,O
106621,8,NS,B-Drug
106621,8,bolus,O
106621,8,then,O
106621,8,NS,B-Drug
106621,8,at,O
106621,8,125cc/hr,O
106621,8,;,O
106621,8,check,O
106621,8,fluid,O
106621,8,status,O
106621,8,closely,O
106621,8,-,O
106621,8,daily,O
106621,8,lytes,O
106621,8,;,O
106621,8,watch,O
106621,8,for,O
106621,8,rising,O
106621,8,sodium,O
106621,8,-,O
106621,8,dysphagia,O
106621,8,diet,O
106621,8,",",O
106621,8,thickened,O
106621,8,liquids,O
106621,8,;,O
106621,8,may,O
106621,8,need,O
106621,8,speech/swallow,O
106621,8,eval,O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,Code,O
106621,8,status,O
106621,8,:,O
106621,8,with,O
106621,8,his,O
106621,8,psychosis,O
106621,8,",",O
106621,8,he,O
106621,8,was,O
106621,8,made,O
106621,8,DNR/DNI,O
106621,8,by,O
106621,8,his,O
106621,8,sister,O
106621,8,(,O
106621,8,due,O
106621,8,to,O
106621,8,his,O
106621,8,advanced,O
106621,8,myeloma,O
106621,8,),O
106621,8,when,O
106621,8,he,O
106621,8,did,O
106621,8,not,O
106621,8,have,O
106621,8,capacity,O
106621,8,to,O
106621,8,make,O
106621,8,medical,O
106621,8,decisions,O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,Communication,O
106621,8,:,O
106621,8,sister,O
106621,8,[,O
106621,8,**Name,O
106621,8,(,O
106621,8,NI,O
106621,8,),O
106621,8,18882**,O
106621,8,],O
106621,8,[,O
106621,8,**Name,O
106621,8,(,O
106621,8,NI,O
106621,8,),O
106621,8,634**,O
106621,8,],O
106621,8,(,O
106621,8,[,O
106621,8,**Telephone/Fax,O
106621,8,(,O
106621,8,1,O
106621,8,),O
106621,8,18883**,O
106621,8,],O
106621,8,.,O
106621,8,#,O
106621,8,#,O
106621,8,Dispo,O
106621,8,:,O
106621,8,pt,O
106621,8,is,O
106621,8,deconditioned,O
106621,8,and,O
106621,8,unsteady,O
106621,8,on,O
106621,8,his,O
106621,8,feet,O
106621,8,and,O
106621,8,",",O
106621,8,per,O
106621,8,primary,O
106621,8,team,O
106621,8,and,O
106621,8,PT,O
106621,8,",",O
106621,8,needs,O
106621,8,rehab,O
106621,8,Medications,O
106621,8,on,O
106621,8,Admission,O
106621,8,:,O
106621,8,Atorvastatin,B-Drug
106621,8,20,O
106621,8,mg,O
106621,8,qd,O
106621,8,Diltiazem,B-Drug
106621,8,SR,I-Drug
106621,8,240,O
106621,8,mg,O
106621,8,Capsule,O
106621,8,qd,O
106621,8,OxyContin,B-Drug
106621,8,20,O
106621,8,mg,O
106621,8,Q12H,O
106621,8,ddAVP,B-Drug
106621,8,[,O
106621,8,**Hospital1,O
106621,8,**,O
106621,8,],O
106621,8,Dexamethasone,B-Drug
106621,8,8,O
106621,8,mg,O
106621,8,[,O
106621,8,**Hospital1,O
106621,8,**,O
106621,8,],O
106621,8,Metoprolol,B-Drug
106621,8,100mg,O
106621,8,tid,O
106621,8,Warfarin,B-Drug
106621,8,2.5mg,O
106621,8,qd,O
106621,8,Advair,B-Drug
106621,8,250-50mcg,O
106621,8,[,O
106621,8,**Hospital1,O
106621,8,**,O
106621,8,],O
106621,8,Oxycodone,B-Drug
106621,8,prn,O
106621,8,Albuterol,B-Drug
106621,8,MDI,O
106621,8,prn,O
106621,8,Atrovent,B-Drug
106621,8,MDI,O
106621,8,prn,O
106621,8,Senna,B-Drug
106621,8,prn,O
106621,9,Discharge,O
106621,9,Medications,O
106621,9,:,O
106621,9,1,O
106621,9,.,O
106621,9,Albuterol,B-Drug
106621,9,90,O
106621,9,mcg/Actuation,O
106621,9,Aerosol,O
106621,9,Sig,O
106621,9,:,O
106621,9,1-2,O
106621,9,Puffs,O
106621,9,Inhalation,O
106621,9,every,O
106621,9,4-6,O
106621,9,hours,O
106621,9,as,O
106621,9,needed,O
106621,9,for,O
106621,9,shortness,B-Reason
106621,9,of,I-Reason
106621,9,breath,I-Reason
106621,9,or,O
106621,9,wheezing,B-Reason
106621,9,.,O
106621,9,2,O
106621,9,.,O
106621,9,Ipratropium,B-Drug
106621,9,Bromide,I-Drug
106621,9,17,O
106621,9,mcg/Actuation,O
106621,9,Aerosol,O
106621,9,Sig,O
106621,9,:,O
106621,9,Two,O
106621,9,(,O
106621,9,2,O
106621,9,),O
106621,9,Puff,O
106621,9,Inhalation,O
106621,9,Q4H,O
106621,9,(,O
106621,9,every,O
106621,9,4,O
106621,9,hours,O
106621,9,),O
106621,9,as,O
106621,9,needed,O
106621,9,for,O
106621,9,shortness,B-Reason
106621,9,of,I-Reason
106621,9,breath,I-Reason
106621,9,or,O
106621,9,wheezing,B-Reason
106621,9,.,O
106621,9,3,O
106621,9,.,O
106621,9,Docusate,B-Drug
106621,9,Sodium,I-Drug
106621,9,100,O
106621,9,mg,O
106621,9,Capsule,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Capsule,O
106621,9,PO,O
106621,9,BID,O
106621,9,(,O
106621,9,2,O
106621,9,times,O
106621,9,a,O
106621,9,day,O
106621,9,),O
106621,9,.,O
106621,9,4,O
106621,9,.,O
106621,9,Oxycodone,B-Drug
106621,9,20,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,12HR,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,12HR,O
106621,9,PO,O
106621,9,Q12H,O
106621,9,(,O
106621,9,every,O
106621,9,12,O
106621,9,hours,O
106621,9,),O
106621,9,:,O
106621,9,give,O
106621,9,with,O
106621,9,10mg,O
106621,9,tablet,O
106621,9,for,O
106621,9,total,O
106621,9,dose,O
106621,9,of,O
106621,9,30mg,O
106621,9,q12h,O
106621,9,.,O
106621,9,5,O
106621,9,.,O
106621,9,Oxycodone,B-Drug
106621,9,10,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,12HR,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,12HR,O
106621,9,PO,O
106621,9,twice,O
106621,9,a,O
106621,9,day,O
106621,9,:,O
106621,9,give,O
106621,9,with,O
106621,9,20mg,O
106621,9,tablet,O
106621,9,for,O
106621,9,total,O
106621,9,dose,O
106621,9,of,O
106621,9,30mg,O
106621,9,q12h,O
106621,9,.,O
106621,9,6,O
106621,9,.,O
106621,9,Toprol,B-Drug
106621,9,XL,I-Drug
106621,9,100,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,24HR,O
106621,9,Sig,O
106621,9,:,O
106621,9,Three,O
106621,9,(,O
106621,9,3,O
106621,9,),O
106621,9,Tablet,O
106621,9,Sustained,O
106621,9,Release,O
106621,9,24HR,O
106621,9,PO,O
106621,9,once,O
106621,9,a,O
106621,9,day,O
106621,9,.,O
106621,9,7,O
106621,9,.,O
106621,9,Fentanyl,B-Drug
106621,9,50,O
106621,9,mcg/hr,O
106621,9,Patch,O
106621,9,72HR,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Patch,O
106621,9,72HR,O
106621,9,Transdermal,O
106621,9,Q72H,O
106621,9,(,O
106621,9,every,O
106621,9,72,O
106621,9,hours,O
106621,9,),O
106621,9,.,O
106621,9,8,O
106621,9,.,O
106621,9,Senna,B-Drug
106621,9,8.6,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Tablet,O
106621,9,PO,O
106621,9,BID,O
106621,9,(,O
106621,9,2,O
106621,9,times,O
106621,9,a,O
106621,9,day,O
106621,9,),O
106621,9,as,O
106621,9,needed,O
106621,9,for,O
106621,9,constipation,B-Reason
106621,9,.,O
106621,9,9,O
106621,9,.,O
106621,9,Diltiazem,B-Drug
106621,9,HCl,I-Drug
106621,9,30,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sig,O
106621,9,:,O
106621,9,One,O
106621,9,(,O
106621,9,1,O
106621,9,),O
106621,9,Tablet,O
106621,9,PO,O
106621,9,QID,O
106621,9,(,O
106621,9,4,O
106621,9,times,O
106621,9,a,O
106621,9,day,O
106621,9,),O
106621,9,:,O
106621,9,hold,O
106621,9,for,O
106621,9,HR,O
106621,9,<,O
106621,9,55,O
106621,9,",",O
106621,9,SBP,O
106621,9,<,O
106621,9,100,O
106621,9,.,O
106621,9,10,O
106621,9,.,O
106621,9,Oxycodone,B-Drug
106621,9,5,O
106621,9,mg,O
106621,9,Tablet,O
106621,9,Sig,O
106621,9,:,O
106621,9,1-2,O
106621,9,Tablets,O
106621,9,PO,O
106621,9,every,O
106621,9,4-6,O
106621,9,hours,O
106621,9,as,O
106621,9,needed,O
106621,9,for,O
106621,9,pain,B-Reason
106621,9,.,O
106621,9,Discharge,O
106621,9,Disposition,O
106621,9,:,O
106621,9,Extended,O
106621,9,Care,O
106621,9,Facility,O
106621,9,:,O
106621,9,[,O
106621,9,**Hospital1,O
106621,9,**,O
106621,9,],O
106621,9,Senior,O
106621,9,Living,O
106621,9,Discharge,O
106621,9,Diagnosis,O
106621,9,:,O
106621,9,Primary,O
106621,9,diagnosis,O
106621,9,:,O
106621,9,change,O
106621,9,in,O
106621,9,mental,O
106621,10,status,O
106621,10,",",O
106621,10,multiple,O
106621,10,myeloma,O
106621,10,",",O
106621,10,steroid,B-Drug
106621,10,psychosis,O
106621,10,Secondary,O
106621,10,diagnosis,O
106621,10,:,O
106621,10,paroxysmal,O
106621,10,atrial,O
106621,10,fibrillation,O
106621,10,",",O
106621,10,hypertension,O
106621,10,",",O
106621,10,osteoarthritis,O
106621,10,s/p,O
106621,10,bilateral,O
106621,10,knee,O
106621,10,replacements,O
106621,10,",",O
106621,10,restrictive,O
106621,10,and,O
106621,10,obstructive,O
106621,10,pulmonary,O
106621,10,disease,O
106621,10,Discharge,O
106621,10,Condition,O
106621,10,:,O
106621,10,stable,O
106621,10,Discharge,O
106621,10,Instructions,O
106621,10,:,O
106621,10,You,O
106621,10,were,O
106621,10,admitted,O
106621,10,to,O
106621,10,the,O
106621,10,hospital,O
106621,10,after,O
106621,10,an,O
106621,10,acute,O
106621,10,change,O
106621,10,in,O
106621,10,your,O
106621,10,mental,O
106621,10,status,O
106621,10,which,O
106621,10,required,O
106621,10,intubation,O
106621,10,in,O
106621,10,order,O
106621,10,to,O
106621,10,protect,O
106621,10,your,O
106621,10,airway,O
106621,10,.,O
106621,10,After,O
106621,10,you,O
106621,10,were,O
106621,10,extubated,O
106621,10,",",O
106621,10,you,O
106621,10,were,O
106621,10,sent,O
106621,10,from,O
106621,10,the,O
106621,10,intensive,O
106621,10,care,O
106621,10,unit,O
106621,10,to,O
106621,10,the,O
106621,10,floor,O
106621,10,.,O
106621,10,While,O
106621,10,on,O
106621,10,the,O
106621,10,floor,O
106621,10,",",O
106621,10,you,O
106621,10,again,O
106621,10,had,O
106621,10,an,O
106621,10,abrupt,O
106621,10,change,O
106621,10,in,O
106621,10,your,O
106621,10,mental,O
106621,10,status,O
106621,10,where,O
106621,10,you,O
106621,10,were,O
106621,10,hallucinating,B-ADE
106621,10,and,O
106621,10,feeling,O
106621,10,very,O
106621,10,paranoid,B-ADE
106621,10,;,O
106621,10,it,O
106621,10,is,O
106621,10,thought,O
106621,10,that,O
106621,10,this,O
106621,10,was,O
106621,10,due,O
106621,10,to,O
106621,10,your,O
106621,10,high,O
106621,10,steroid,B-Drug
106621,10,dose,O
106621,10,which,O
106621,10,has,O
106621,10,since,O
106621,10,been,O
106621,10,stopped,O
106621,10,.,O
106621,10,Your,O
106621,10,warfarin,B-Drug
106621,10,(,O
106621,10,Coumadin,B-Drug
106621,10,),O
106621,10,has,O
106621,10,been,O
106621,10,stopped,O
106621,10,due,O
106621,10,to,O
106621,10,bleeding,B-ADE
106621,10,risks,O
106621,10,.,O
106621,10,Your,O
106621,10,intranasal,O
106621,10,ddAVP,B-Drug
106621,10,was,O
106621,10,stopped,O
106621,10,since,O
106621,10,we,O
106621,10,do,O
106621,10,not,O
106621,10,believe,O
106621,10,that,O
106621,10,you,O
106621,10,need,O
106621,10,it,O
106621,10,.,O
106621,10,You,O
106621,10,are,O
106621,10,being,O
106621,10,discharged,O
106621,10,to,O
106621,10,a,O
106621,10,rehab,O
106621,10,facility,O
106621,10,so,O
106621,10,that,O
106621,10,you,O
106621,10,may,O
106621,10,regain,O
106621,10,your,O
106621,10,strength,O
106621,10,.,O
106621,10,Please,O
106621,10,attend,O
106621,10,all,O
106621,10,follow-up,O
106621,10,appointments,O
106621,10,.,O
106621,10,Please,O
106621,10,take,O
106621,10,all,O
106621,10,medications,O
106621,10,as,O
106621,10,prescribed,O
106621,10,.,O
106621,10,Followup,O
106621,10,Instructions,O
106621,10,:,O
106621,10,Provider,O
106621,10,:,O
106621,10,[,O
106621,10,**First,O
106621,10,Name8,O
106621,10,(,O
106621,10,NamePattern2,O
106621,10,),O
106621,10,539**,O
106621,10,],O
106621,10,[,O
106621,10,**Last,O
106621,10,Name,O
106621,10,(,O
106621,10,NamePattern1,O
106621,10,),O
106621,10,9816**,O
106621,10,],O
106621,10,",",O
106621,10,RN,O
106621,10,Phone,O
106621,10,:,O
106621,10,[,O
106621,10,**Telephone/Fax,O
106621,10,(,O
106621,10,1,O
106621,10,),O
106621,10,3241**,O
106621,10,],O
106621,10,Date/Time,O
106621,10,:,O
106621,10,[,O
106621,10,**2167-9-15**,O
106621,10,],O
106621,10,11:00,O
106621,10,Provider,O
106621,10,:,O
106621,10,[,O
106621,10,**First,O
106621,10,Name11,O
106621,10,(,O
106621,10,Name,O
106621,10,Pattern1,O
106621,10,),O
106621,10,1730**,O
106621,10,],O
106621,10,[,O
106621,10,**Last,O
106621,10,Name,O
106621,10,(,O
106621,10,NamePattern4,O
106621,10,),O
106621,10,6175**,O
106621,10,],O
106621,10,",",O
106621,10,MD,O
106621,10,Phone,O
106621,10,:,O
106621,10,[,O
106621,10,**Telephone/Fax,O
106621,10,(,O
106621,10,1,O
106621,10,),O
106621,10,3237**,O
106621,10,],O
106621,10,Date/Time,O
106621,10,:,O
106621,10,[,O
106621,10,**2167-9-15**,O
106621,10,],O
106621,10,11:00,O
106621,10,Provider,O
106621,10,:,O
106621,10,[,O
106621,10,**First,O
106621,10,Name8,O
106621,10,(,O
106621,10,NamePattern2,O
106621,10,),O
106621,10,**,O
106621,10,],O
106621,10,[,O
106621,10,**Last,O
106621,10,Name,O
106621,10,(,O
106621,10,NamePattern1,O
106621,10,),O
106621,10,11755**,O
106621,10,],O
106621,10,",",O
106621,10,[,O
106621,10,**MD,O
106621,10,Number,O
106621,10,(,O
106621,10,3,O
106621,10,),O
106621,10,1240**,O
106621,10,],O
106621,10,:,O
106621,10,[,O
106621,10,**Telephone/Fax,O
106621,10,(,O
106621,10,1,O
106621,10,),O
106621,10,3237**,O
106621,10,],O
106621,10,Date/Time,O
106621,10,:,O
106621,10,[,O
106621,10,**2167-9-15**,O
106621,10,],O
106621,10,11:00,O
